| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |